Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age
Description:
Safety, dose-escalation and dose-confirmation Phase I study testing single-component GBS-NN vaccine composition.
Status:
Study is completed and has published results
Countries:
UK
Links
Pawlowski et al 2022: